Company intelligence / Profile preview

Guangzhou Anjie Biomedical Technology Co., Ltd.

Guangzhou, Guangdong, Chinagzbiogene.com ↗

Ownership: Private
Development stage: Other

Overview

The company has developed a pipeline of next-generation CAR-T therapies, including anti-MUC1 CAR-T for prostate cancer in Phase 2, and CRISPR-edited PD-1 knockout T cells for solid tumors. Early clinical results suggest safety and efficacy in eliminating tumor cells, particularly in collaboration with leading Chinese hospitals. Several programs are ongoing or pending further clinical advancement. No commercialized products as of May 2025.

Therapeutic areas: Oncology
Modalities: CAR-T cells (including next-generation and bispecific CAR-T)CRISPR-edited T cells (PD-1 knockout)
Industry: Biotech

Drug pipeline

5 assets

anti-muc1 car-t cells

4 more assets in the full pipeline.

Partnerships

Collaborations with ~20 top Chinese hospitals for clinical research on novel cell therapies; no major pharma partnerships disclosed publicly.

Beyond the preview

Go deeper on Guangzhou Anjie Biomedical Technology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Anjie Biomedical Technology Co., Ltd..